Gamma Pharmaceuticals Secures Registered Trademark Protection in China

LAS VEGAS, NV and BEIJING, Oct 29 (MARKET WIRE) --
Gamma Pharmaceuticals Inc. (the "Company") (PINKSHEETS: GMPM) announced
it has successfully completed the registration of six of the Company's
Brand Trademarks with The State Trademark Bureau of China. This important
milestone is the conclusion of a two-year registration process and will
provide Gamma with exclusivity of use and trademark protection on its
commercial products in China.

Mr. Hao Zhang, Gamma's Chief Marketing Officer and China Representative,
stated, "We are pleased to have the proper protection for our brands and
recourse should there be any infringement. The Chinese nutritional
supplement market is growing rapidly and we need to have the correct legal
protections as we push our brand identity."

Gamma has a wholly owned subsidiary in Hong Kong and a Representative
office in Beijing to facilitate its Asian business. Gamma's three founders
have substantial business experience in Asia, having lived and worked
there for nearly two decades. Gamma's management views the rapidly growing
Chinese market as a key growth driver for the Company and have budgeted
approximately $13 million in revenues for 2010 from the region. Gamma's
intellectual property assets total nearly $6 million on the Company's
balance sheet. Management's extensive Intellectual Property Management
Program is designed to both protect these important assets and to grow
their value.

About Gamma Pharmaceuticals Inc

Gamma Pharmaceuticals Inc., (www.gammapharma.com) is a marketing and
product formulation company selling its own branded products through
wholesalers and direct to retailers, both in the US and internationally.
Gamma's core focus is the marketing and sale of vitamins and
nutriceuticals, OTC pharmaceutical products and personal care products in
Greater China and the United States. Branded nutritional supplements are
sold under the trademarks Brilliant Choice(TM) children's nutritional
supplements featuring the call to action, "Mom, you've made a brilliant
choice for your children's nutrition"; SAVVY(TM) adult nutritional
supplements featuring the call to action, "Be SAVVY Stay Healthy"; and
Jugular Energy Products(TM) and high performance supplements featuring the
call to action, "Go for the Jugular(TM)." Gamma's customer focus is on
selling products in the Lifestyle of Health & Sustainability ("LOHAS")
marketplace and in the Energy Supplement Market. A series of innovative
marketing programs support Gamma's product sales and retail partners.

At present, Gamma manufactures in North America, and distributes in the
United States and China. Gamma's products utilize proprietary "Gel
Delivery Technology(R)" to create innovative gel product forms that give
consumers a more pleasant experience. Gel Delivery Technology(R)
characteristics include rapid absorption, convenience and superior taste.
Market categories Gamma targets are growing as rapidly as 60% per year.
Gamma has developed formulas and strategies for Metabolic Syndrome and
Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause
Symptoms, and Personal Care Products. Gamma also develops and manufactures
house brands for major retailers. At this time, Gamma has a total of 36
SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. The statements in this Press Release regarding any impact the
quotation of the Company's stock has on the Pink Sheets or the lack
thereof on the OTCBB, and any other effects of the above are
forward-looking statements. Such statements are subject to certain risks
and uncertainties, and actual circumstances, events or results may differ
materially from those projected in such forward-looking statements. The
Company cautions readers not to place undue reliance on any
forward-looking statements. The Company does not undertake, and
specifically disclaims any obligation, to update or revise such
statements to reflect new circumstances or unanticipated events as they
occur.

Contact:
Gamma Pharmaceuticals Inc
Joe Cunningham
(jcunningham@gammapharma.com)
Office: (702) 989 5262
Direct: (651) 204 2048

Copyright 2009, Market Wire, All rights reserved.

-0-